Home/Filings/4/0001310204-26-000002
4//SEC Filing

Dickinson Andrew D 4

Accession 0001310204-26-000002

CIK 0000882095other

Filed

Jan 15, 7:00 PM ET

Accepted

Jan 16, 6:18 PM ET

Size

4.8 KB

Accession

0001310204-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-15
Dickinson Andrew D
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    [F1]
    2026-01-15$124.31/sh3,000$372,930150,503 total
Footnotes (1)
  • [F1]The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
Signature
/s/ Amy Kim by Power of Attorney for Andrew D. Dickinson|2026-01-16

Issuer

GILEAD SCIENCES, INC.

CIK 0000882095

Entity typeother

Related Parties

1
  • filerCIK 0001310204

Filing Metadata

Form type
4
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 6:18 PM ET
Size
4.8 KB